accountBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the appointment of Mr. Thomas R. Staab, II as BioCryst?s new Chief Financial Officer, effective July 1, 2011, and that Mr. Stuart R. Grant, BioCryst?s current CFO, has agreed to extend his...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to BioCryst Pharmaceuticals Announces Appointment Of Thomas Staab As Its Next Chief Financial Officer
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account